Thoracic Cancer
65
16
19
27
Key Insights
Highlights
Success Rate
84% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.7%
5 terminated out of 65 trials
84.4%
-2.2% vs benchmark
2%
1 trials in Phase 3/4
15%
4 of 27 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 27 completed trials
Clinical Trials (65)
Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study
LUCINAE Registry: Thoracic Cancers During Pregnancy
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Prospective Data Collection Initiative on Thoracic Malignancies
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Evaluation of On-Couch CBCT Image Quality
Variability and Post-op AEs: Does Preoperative CardioPulmonary Variability Assessment Identify Risk of Postoperative Adverse Events Following Thoracic Surgery
Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
Thoracic Surgery by the Medtronic Hugo™ Robotic System
Curatively Intended Thoracic Reirradiation
Preoperative Smoking Cessation in Patients Undergoing Surgery
Erector Spinae Block for Thoracic Surgery
Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity
Pilot Study to Determine Pro-Inflammatory Cytokine Kinetics During Immune Checkpoint Inhibitor Therapy
An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer
SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT